Sage Journals: Discover world-class research

Retricted access

Review article

First published 1998-12

Toxicity Management in Patients Receiving Low-Dose Aldesleukin Therapy

David J Sundin, Maurice J Wolin

Annals of Pharmacotherapy

Retricted access

Case report

First published 2012-5

Dantrolene Sodium for the Treatment of Aldesleukin-lnduced Rigors in a Melanoma Patient

Laleh M Azari, Vivien S Sheehan, Jasgit C Sachdev [...]

Annals of Pharmacotherapy

Retricted access

News

First published 1999-04

{BLR 2864} Aldesleukin-Canada-Chiron-EuropeMelanoma-Perssis

Biotechnology Law Report

Retricted access

Research article

First published 2006-03

Reduced Secondary Cytokine Induction by BAY 50-4798,a High-Affinity Receptor-Specific Interleukin-2 Analog

Sonja Steppan, Michael R. Eckart, Krystyna Bajsarowicz [...]

Journal of Interferon & Cytokine Research

Retricted access

Other

First published 1997-9

Hepatitis B Vaccine: Current Issues

Raffaella Zannolli, Guido Morgese

Annals of Pharmacotherapy

Retricted access

Other

First published 2011-9

Cost savings from dose rounding of biologic anticancer agents in adults

Brenda J Winger, Elizabeth A Clements, Jaculin L DeYoung [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2016-5

Dinutuximab

Cady Ploessl, Alice Pan, Kathryn T. Maples [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 1999-6

Treatment of Malignant Melanoma

Esther Durán García, Rosario Santolaya, Teresa Requena

Annals of Pharmacotherapy

Retricted access

Research article

First published 2012-6

Reporting on Adverse Clinical Events

Clin-Alert

Retricted access

Research article

First published 2013-2

Targeted Immunotherapy for High-Risk Neuroblastoma—The Role of Monoclonal Antibodies

Kerry Parsons, Brooke Bernhardt, Brandy Strickland

Annals of Pharmacotherapy

Search results